๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I and II clinical trial design for targeted agents

โœ Scribed by Richard L. Schilsky

Book ID
107384265
Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
151 KB
Volume
1
Category
Article
ISSN
1776-2596

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Optimal three-stage designs for phase II
Optimal three-stage designs for phase II cancer clinical trials
โœ T. Timothy Chen ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 136 KB ๐Ÿ‘ 2 views

The objective of a phase II cancer clinical trial is to screen a treatment that can produce a similar or better response rate compared to the current treatment results. This screening is usually carried out in two stages as proposed by Simon. For ineffective treatment, the trial should terminate at

KSTAGE: An interactive computer program
KSTAGE: An interactive computer program for designing phase II clinical trials using predictive probability
โœ E.Neely Atkinson; Barry W. Brown; Jay Herson ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 450 KB

Early termination of clinical trials is advisable if initial evidence indicates the treatment under study is ineffective. Predictive probability methods permit the construction of multistage studies that allow for early termination while still controlling overall false-positive (declare an ineffecti